Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Undergraduate Student Research Awards (USRA)

University of Ottawa

$6,000.00

Enhancing Senescent Cell Clearance by Lung-Resident iNKT Cells in Pulmonary Hypertension

EF 2026-27

Résumé
Background- Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by occlusive arterial remodeling and right ventricular failure. Our recent studies link PAH progression to the accumulation of senescent cells (SCs), which secrete pro-inflammatory and pro-fibrotic mediators known as the senescence-associated secretory phenotype (SASP). While immune surveillance normally eliminates SCs, impaired clearance leads to their pathological accumulation in chronic disease. Invariant natural killer T (iNKT) cells bridge innate and adaptive immunity and may participate in SC elimination, but their role in PAH remains poorly understood. Objective- We hypothesize that activation of lung-resident iNKT cells will enhance immune-mediated SC clearance, thereby attenuating vascular remodeling. This project will evaluate how iNKT activation alters SASP expression in PAH lung tissues. Methods- PAH is induced in rats using the SU5416/hypoxia model. SC accumulation is assessed via beta-galactosidase and p16 staining. Lung immune populations are analyzed using scRNA-seq and flow cytometry. iNKT cells are activated by IP administration of alpha-galactosylceramide (alpha-GalCer). The student will characterize changes in SASP-related inflammatory mediators using quantitative PCR (qPCR) to assess key SASP factors and determine how iNKT activation influences senescence-associated signaling. Results- Preliminary data shows alpha-GalCer reduces pulmonary hypertension and improves ventricular function. We expect treatment to significantly reduce pro-inflammatory SASP factors (eg: IL-6, IL-1beta). This work will clarify how immune modulation promotes SC clearance, supporting new immunotherapeutic strategies for pulmonary vascular disease.
Programme
Undergraduate Student Research Awards (USRA)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
571599
Name
Djofang de Ngankam Franck
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Enhancing Senescent Cell Clearance by Lung-Resident iNKT Cells in Pulmonary Hypertension
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Ottawa
Cihramount2
$6,000
Cihrequipment2
$0
Programname2
Undergraduate Student Research Awards (USRA)
Keyworddelim
Occlusive Arterial Remodeling; Pulmonary Arterial Hypertension; Senescent Cells; Ventricular Failure
Abstract
Background- Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by occlusive arterial remodeling and right ventricular failure. Our recent studies link PAH progression to the accumulation of senescent cells (SCs), which secrete pro-inflammatory and pro-fibrotic mediators known as the senescence-associated secretory phenotype (SASP). While immune surveillance normally eliminates SCs, impaired clearance leads to their pathological accumulation in chronic disease. Invariant natural killer T (iNKT) cells bridge innate and adaptive immunity and may participate in SC elimination, but their role in PAH remains poorly understood. Objective- We hypothesize that activation of lung-resident iNKT cells will enhance immune-mediated SC clearance, thereby attenuating vascular remodeling. This project will evaluate how iNKT activation alters SASP expression in PAH lung tissues. Methods- PAH is induced in rats using the SU5416/hypoxia model. SC accumulation is assessed via beta-galactosidase and p16 staining. Lung immune populations are analyzed using scRNA-seq and flow cytometry. iNKT cells are activated by IP administration of alpha-galactosylceramide (alpha-GalCer). The student will characterize changes in SASP-related inflammatory mediators using quantitative PCR (qPCR) to assess key SASP factors and determine how iNKT activation influences senescence-associated signaling. Results- Preliminary data shows alpha-GalCer reduces pulmonary hypertension and improves ventricular function. We expect treatment to significantly reduce pro-inflammatory SASP factors (eg: IL-6, IL-1beta). This work will clarify how immune modulation promotes SC clearance, supporting new immunotherapeutic strategies for pulmonary vascular disease.
Competitiondate
202605
Approvedterm2
0 yr 4 mths
Pinamesdelim
Djofang de Ngankam, Franck
Approvedterm
0 an 4 mois
Cihrcontribution2
~ $6,000~ $0~